Whole Oyster Extract Can Address Gut Issues and Reduce Marine Waste
The balance of the intestinal lining is crucial for overall body health. When inflammation disrupts this balance, the risk of various chronic diseases, such as inflammatory bowel disease and type 2 diabetes, increases. Interestingly, a natural solution to this problem may come from marine farming waste that is often discarded.
A recent study by a team of scientists from the University of Ferrara (Unife) in Italy found that an extract from whole Pacific oyster (Crassostrea gigas) meat can relieve inflammation in human intestinal cells while protecting the intestinal barrier. This discovery opens up significant opportunities to turn oysters that do not meet commercial standards into high-value health products.
The human intestinal wall consists of a single, tight layer of cells that acts as a fortress, controlling substances that enter the body. When this layer weakens, a condition known as leaky gut, bacteria and toxins can slip into the bloodstream. This triggers a continuous activation of the immune system, known as chronic inflammation.
The research, led by Giulia Trinchera, a doctoral student at Unife, focused on the Pacific oyster, the most widely farmed saltwater shellfish species in the world. In an interview with Earth.com, Trinchera expressed surprise at the laboratory findings. “What was most surprising was that the extract of the whole soft oyster tissue, not purified peptides or isolated compounds, was able to provide a consistent anti-inflammatory effect on intestinal epithelial models,” Trinchera said.
In their experiments, the research team collected adult oysters from the Po River delta in northern Italy. The oyster meat was freeze-dried, ground, and extracted using alcohol to capture its active compounds. When tested on inflamed human intestinal cells, the oyster extract blocked a key inflammatory switch and reduced the activity of inflammatory genes by half at the highest dose. Furthermore, the extract lowered levels of the COX-2 enzyme, which propagates inflammation. “To the best of our knowledge, this is the first time that oyster tissue has been shown to exert an anti-inflammatory effect on intestinal cells,” Trinchera added.
Beyond chemically relieving inflammation, the oyster extract also maintained the physical strength of the intestinal wall. Under an electron microscope, intestinal cells treated with a high dose of the extract appeared smooth and tight, in stark contrast to the damaged and perforated appearance of untreated, inflamed cells.
In addition to its health benefits, this innovation offers an environmental solution. The oysters studied came from Sacca di Goro, Italy, where approximately 30-40% of the annual harvest is discarded because the shellfish are too small or misshapen. Trinchera explained that the findings show these discarded oysters can be a valuable source of bioactive materials for nutraceutical applications, contributing to a more circular and sustainable aquaculture economy and creating added value from existing marine resources.
Despite the promising results, Trinchera stressed that the research is still a proof of concept. She noted that many questions remain regarding efficacy, safety, dosage, and how the active compounds behave in a living organism. Animal and human trials will be the next crucial steps before the extract can officially become a commercial supplement.